ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Potential aggregation prone regions in biotherapeutics A survey of commercial monoclonal antibodies

Wang, Xiaoling; Das, Tapan K.; Singh, Satish K.; Kumar, Sandeep*
mAbs2009-5DOI: 10.4161/mabs.1.3.8035
125被引6阅读
引用收藏
分享

摘要

Aggregation of a biotherapeutic is of significant concern and judicious process and formulation development is required to minimize aggregate levels in the final product. Aggregation of a protein in solution is driven by intrinsic and extrinsic factors. In this work we have focused on aggregation as an intrinsic property of the molecule. We have studied the sequences and Fab structures of commercial and non-commercial antibody sequences for their vulnerability towards aggregation by using sequence based computational tools to identify potential aggregation-prone motifs or regions. The mAbs in our dataset contain 2 to 8 aggregation-prone motifs per heavy and light chain pair. Some of these motifs are located in variable domains, primarily in CDRS. Most aggregation-prone motifs are rich in beta branched aliphatic and aromatic residues. Hydroxyl-containing Ser/Thr residues are also found in several aggregation-prone motifs while charged residues are rare. The motifs found in fight chain CDR3 are glutamine (Q)/asparagine (N) rich. These motifs are similar to the reported aggregation promoting regions found in prion and amyloidogenic proteins that are also rich in Q/N, aliphatic and aromatic residues. The implication is that one possible mechanism for aggregation of mAbs may be through formation of cross-beta structures and fibrils. Mapping on the available Fab-receptor/antigen complex structures reveals that these motifs in CDRs might also contribute significantly towards receptor/antigen binding. Our analysis identifies the opportunity and tools for simultaneous optimization of the therapeutic protein sequence for potency and specificity while reducing vulnerability towards aggregation.

学科与关键词

关键词
monoclonal antibodyaggregationantibody sequenceaggregation-prone regionaggregation prediction
相关
加载中…
  • Aggregation in Protein-Based Biotherapeutics: Computational Studies and Tools to Identify Aggregation-Prone Regions
    Agrawal, Neeraj J.; Kumar, Sandeep*; Wang, Xiaoling; Helk, Bernhard; Singh, Satish K.; Trout, Bernhardt L.Journal of Pharmaceutical Sciences, 2011, 100(12): 5081-5095.被引 113
  • Protein aggregation in silico
    Cellmer, Troy; Bratko, Dusan; Prausnitz, John M.; Blanch, Harvey W.*Trends in Biotechnology, 2007, 25(6): 254-261.被引 54
  • Evaluation of the impact of antibody fragments on aggregation of intact molecules via size exclusion chromatography coupled with native mass spectrometry
    Xu, Jing; Coughlin, John E.; Szyjka, Malgorzata; Jabary, Serene; Saluja, Sonal; Sosic, Zoran; Chen, Yunqiu*; Xu, Chong-Feng*mAbs, 2024, 16(1): 2334783.
查看全部 →

发表信息

论文状态
公开发表
期刊
mAbs
发表日期
2009-05
卷期
第 1 卷, 第 3 期
页码
254-267
DOI
10.4161/mabs.1.3.8035
语言
ENGLISH
成果收录
SCIE

作者

  • W

    Wang, Xiaoling (第一作者)

  • D

    Das, Tapan K.

查看全部 4 位作者收起作者
  • S

    Singh, Satish K.

  • K

    Kumar, Sandeep (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417